Home > Insider Trading > Filing (0001594631-17-000005)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1457612	Genocea Biosciences Inc.	GNCA	Biological Products, (No Disgnostic Substances) (2836)	510596811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1594631	George Siber	2000 Broadway Penthouse 2B New York NY 10023		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-18	1,680	$2.38	3,697	No	4	M	Direct
Common Stock	Acquisiton	2017-05-18	10,084	$1.67	13,781	No	4	M	Direct
Common Stock	Acquisiton	2017-05-18	19,281	$2.38	33,062	No	4	M	Direct
Common Stock	Disposition	2017-05-18	31,045	$6.02	2,017	No	4	P	Direct
Common Stock	Acquisiton	2017-05-19	11,230	$2.38	13,247	No	4	M	Direct
Common Stock	Acquisiton	2017-05-19	11,057	$2.86	24,304	No	4	M	Direct
Common Stock	Disposition	2017-05-19	22,287	$6.07	2,017	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	P	Direct
No	4	M	Direct
No	4	M	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to purchase Common Stock	Disposition	2017-05-18	10,084	$1.67	10,084	$1.67
Common Stock	Option to purchase Common Stock	Disposition	2017-05-18	1,680	$2.38	1,680	$2.38
Common Stock	Option to purchase Common Stock	Disposition	2017-05-18	19,281	$2.38	19,281	$2.38
Common Stock	Option to purchase Common Stock	Disposition	2017-05-19	11,230	$2.38	11,230	$2.38
Common Stock	Option to purchase Common Stock	Disposition	2017-05-19	11,057	$2.86	11,057	$2.86

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2017-06-12	No	4	M	Direct
0	2018-06-18	No	4	M	Direct
11,230	2019-06-30	No	4	M	Direct
0	2019-06-30	No	4	M	Direct
0	2020-12-17	No	4	M	Direct

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.00 to $6.05, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.00 to $6.15, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The options of registrant's common stock vested as to 25% of the shares on the one-year anniversary of the grant and in equal monthly installments over the next three years thereafter.
The options of registrant's common stock vested in equal monthly installments over the first four years after the grant.
The options of registrant's common stock vested on the date of the grant.